Evidence map›Paper›PMID 28972927›Full record

ArticleVirology2017

Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry.

John Nahabedian, Amit Sharma, Maryska E Kaczmarek, Greg K Wilkerson, Sara L Sawyer, Julie Overbaugh

Open access · greenAbstract read
In one paragraph

Article in Virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. 5-HTACS chemical neuroscience · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

John NahabedianHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States; Pathobiology, University of Washington, Seattle, WA, United States.
Amit SharmaHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Maryska E KaczmarekDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO, United States.
Greg K WilkersonDepartment of Veterinary Sciences, Michale E. Keeling Center for Comparative Medicine and Research, University of Texas MD Anderson Cancer Center, Bastrop, TX, United States.
Sara L SawyerDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO, United States. Electronic address: ssawyer@colorado.edu.
Julie OverbaughHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States; Pathobiology, University of Washington, Seattle, WA, United States. Electronic address: joverbau@fredhutch.org.
University of Colorado Boulder · USUniversity of Washington · USFred Hutch Cancer Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTIONDP1DA039543 · NIDA · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2015 to 2019
$4.4M
Rapid evolution of genes critical for genome integrityR01GM093086 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI SAWYER, SARA · 2010 to 2016
$1.9M
Host innate immune response as a barrier to cross-species retrovirus transmissionR00AI125136 · NIAID · OHIO STATE UNIVERSITY · PI SHARMA, AMIT · 2019 to 2020
$498k
Host Innate Immune Response as a Barrier to Cross-Species Retrovirus TransmissionK99AI125136 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SHARMA, AMIT · 2016 to 2017
$194k
NIAID NIH HHS K99 AI125136NIAID NIH HHS R00 AI125136NIDA NIH HHS DP1 DA039543NIGMS NIH HHS R01 GM093086NIGMS NIH HHS T32 GM007288
6 · The paper itself

Abstract

Studying HIV-1 replication in the presence of functionally related proteins from different species has helped define host determinants of HIV-1 infection. Humans and owl monkeys, but not macaques, encode a CD4 receptor that permits entry of transmissible HIV-1 variants due to a single residue difference. However, little is known about whether divergent CCR5 receptor proteins act as determinants of host-range. Here we show that both owl monkey (Aotus vociferans) CD4 and CCR5 receptors are functional for the entry of transmitted HIV-1 when paired with human versions of the other receptor. By contrast, the owl monkey CD4/CCR5 pair is generally a suboptimal receptor combination, although there is virus-specific variation in infection with owl monkey receptors. Introduction of the human residues 15Y and 16T within a sulfation motif into owl monkey CCR5 resulted in a gain of function. These findings suggest there is cross-talk between CD4 and CCR5 involving the sulfation motif.

Indexed as

Virus InternalizationAmino Acid SequenceAnimalsAotidaeCD4 AntigensHEK293 CellsHIV-1HumansMutationReceptors, CCR5Virus ReplicationCD4 AntigensReceptors, CCR5CCR5CD4EntryHIV-1Owl monkeyReceptorSpecies differences

Identifiers

PMID28972927
PMCPMC6191650
OpenAlexW2766540924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.